Inventor
KAN PEI
TW18 patents
⚠️ This page may combine multiple inventors who share the name “KAN PEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PHARMOSA BIOPHARM INC
6 patentsUS12551437B2Feb 17, 2026
Liposome compositions comprising weak acid drugs and uses thereof
PHARMOSA BIOPHARM INC0 citations58
US12220483B2Feb 11, 2025
Liposome compositions comprising weak acid drugs and uses thereof
PHARMOSA BIOPHARM INC0 citations58
US11964050B2Apr 23, 2024
Liposome compositions comprising weak acid drugs and uses thereof
PHARMOSA BIOPHARM INC0 citations58
US11833125B2Dec 5, 2023
Pharmaceutical composition for controlled release of treprostinil
PHARMOSA BIOPHARM INC0 citations58
US11229616B2Jan 25, 2022
Pharmaceutical composition for controlled release of treprostinil
PHARMOSA BIOPHARM INC0 citations58
US12064406B2Aug 20, 2024
Pharmaceutical composition of a weak acid drug and methods of administration
PHARMOSA BIOPHARM INC0 citations47
TAIWAN LIPOSOME CO LTD
5 patentsUS10220095B2Mar 5, 2019
Controlled drug release liposome compositions and methods thereof
TAIWAN LIPOSOME CO LTD2 citations69
US9700511B2Jul 11, 2017
Controlled drug release liposome composition
TAIWAN LIPOSOME CO LTD4 citations69
US11147881B2Oct 19, 2021
Controlled drug release liposome compositions and methods thereof
TAIWAN LIPOSOME CO LTD0 citations59
US10980798B2Apr 20, 2021
Pharmaceutical compositions of hydrophobic camptothecin derivatives
TAIWAN LIPOSOME CO LTD0 citations57
US10391056B2Aug 27, 2019
Pharmaceutical compositions of hydrophobic camptothecin derivatives
TAIWAN LIPOSOME CO LTD1 citations53
IND TECH RES INST
3 patentsUS7179867B2Feb 20, 2007
Thermosensitive biodegradable copolymer
IND TECH RES INST15 citations80
US7588778B2Sep 15, 2009
Delivery carrier for targeting to cells expressed with somatostatin receptors
IND TECH RES INST5 citations61
US7485320B2Feb 3, 2009
Liposome for incorporating large amounts of hydrophobic substances
IND TECH RES INST1 citations42